Nanox AI

10/03/2026

06/03/2026

24/02/2026

Nanox’s vision for global medical imaging development is transformational, a combination of hardware, software, and service delivery that applies unique design and AI-based advancements to expand care. At ECR in Vienna, March 4-8, 2026, the company will showcase its Nanox.ARC digital tomosynthesis...

19/02/2026

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution.

Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market.

This collaboration supports the continued expansion of Nanox.ARC across Latin America and strengthens our presence in the region’s private healthcare sector.

Read more here: https://investors.nanox.vision/news-releases/news-release-details/nanox-expands-latin-america-exclusive-nanoxarc-distribution

17/02/2026

Nanox is showcasing its end-to-end imaging solutions, from scan to diagnosis.

Demonstrating the cutting-edge, CE-marked Nanox.ARC in Europe for the first time, and proven results from Nanox.AI solutions.


Read today’s announcement: https://investors.nanox.vision/news-releases/news-release-details/nanox-showcase-nanoxarc-live-europe-first-time-and-present-new

Schedule a meeting with us to learn more:
https://outlook.office.com/bookwithme/user/d23d548e352e4149b2d2b4ff193e6272%40nanox.vision/meetingtype/juC_vUTwy0GHCc4ED0XmZQ2?anonymous&ismsaljsauthenabled&utm_source=linkedin&utm_medium=organic_social&utm_campaign=book_meeting

03/02/2026

TAP2D a new Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems

We’re proud to announce that Nanox has received FDA 510(k) clearance for TAP2D, a new image enhancement capability for Nanox.ARC and Nanox.ARC X Systems.
This milestone marks an important step forward toward the next phase of development, with the goal of ultimately removing the adjunct use in the U.S.
TAP2D provides radiologists with an additional, clear 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation.

Learn more: https://investors.nanox.vision/news-releases/news-release-details/nanox-receives-fda-510k-clearance-tap2d-new-image-enhancement

20/08/2025

Join the webinar to explore the data and learn how Nanox.AI is reshaping bone health

The ADOPT study, coordinated by University of Oxford, analyzed over 37,000 routine CT scans across NHS England sites in Cambridge, Bradford, Cardiff & Southampton. Nanox.AI enabled up to 6x more fracture detections than the UK average

You are invited to the upcoming Webinar:
Use of Artificial Intelligence in a Fracture Liaison Service

Register here:
https://us02web.zoom.us/webinar/register/WN_cvfhYc_aQgGN4ON7g2A50Q #/registration

17/04/2025

First FDA clearance for the new Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications, adjunctive to conventional radiography on adult patients.

Learn more in today’s press release: https://investors.nanox.vision/news-releases/news-release-details/nanox-receives-fda-clearance-general-use-new-imaging-system

Nanox ARC X will become commercially available later this year.

09/04/2025

As the season of renewal begins, the Nanox team extends our best wishes to the healthcare community. May this spring bring new advancements, breakthroughs, and continued dedication to improving patient care.
Together, let’s embrace innovation and growth for a healthier future.
Happy Spring Holidays!